Adverse events leading to discontinuation of daptomycin versus vancomycin in outpatient parenteral antimicrobial therapy: a retrospective cohort study
Kristin Lanier, Jaspaul Jawanda, Allison Cid · 2025
Read Adverse events leading to discontinuation of daptomycin versus vancomycin in outpatient parenteral antimicrobial therapy: a retrospective cohort study by Kristin Lanier, Jaspaul Jawanda, Allison Cid (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12661527.txt.
Description
Kristin Lanier, Jaspaul Jawanda, and Allison Cid compare two antibiotics given by drip at home, watching for side effects bad enough to stop treatment. Their 2025 study reviews outpatients on daptomycin or vancomycin, two workhorse drugs for stubborn infections. Home drip therapy frees hospital beds, but harm at home must be caught by its pattern, not by ward rounds.
The review covered 175 patients, 112 on daptomycin and 63 on vancomycin. Early stopping for harm hit 13 percent of the first group and 14 percent of the second, a gap too small to matter. When harm came, it came sooner on daptomycin, at a median of 12 days against 30. Software-guided dosing may have softened vancomycin's harms. The authors say either drug can serve, chosen patient by patient.
Catalog record
| CREATOR | Kristin Lanier, Jaspaul Jawanda, Allison Cid |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 15 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |